Zobrazeno 1 - 10
of 221
pro vyhledávání: '"R. Geha"'
Autor:
A. Ben Amor, F. Walylo, I. Ghrissi, P. Barsoum, S. Razkallah, R. Geha, J.P. Maroni, T. Filali
Publikováno v:
Archives of Cardiovascular Diseases Supplements. 12:42-43
Objective The underlying pathophysiology of right ventricular (RV) dysfunction in heart failure with preserved ejection fraction (HFpEF) is still debated. The aim of this study is to assess the prognostic significance of echocardiographic right ventr
Autor:
F. Walylo, R. Geha, A. Ben Amor, I. Ghrissi, T. Filali, S. Razkallah, P. Barsoum, J.P. Maroni
Publikováno v:
Archives of Cardiovascular Diseases Supplements. 12:55-56
Background Patients with hypertrophic cardiomyopathy (HCM) are prone to develop atrial fibrillation (AF) due to diastolic dysfunction and left atrial (LA) remodeling. According to guidelines, 48-hour ambulatory ECG is recommended every 12–24 months
Autor:
J, Sayos, C, Wu, M, Morra, N, Wang, X, Zhang, D, Allen, S, van Schaik, L, Notarangelo, R, Geha, M G, Roncarolo, H, Oettgen, J E, De Vries, G, Aversa, C, Terhorst
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950). 199(5)
Approximately 19 years ago, Terhorst and colleagues ([1][1]) reported the cloning of the gene encoding a small adaptor protein, signaling lymphocyte activation molecule (SLAM)-associated protein (SAP), named by virtue of its binding to the intracellu
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
T. Muto, Y. Kawano, C. K. Wong, Y. Kondo, A. Hara, H. Huang, K. Ohmori, S. Saptarshi, H. Saito, F. Kudo, T. Ikeda, W. Ito, H. Nagase, M. Suzukawa, S. Hu, T. Yoshimoto, K. Yasuda, T. Nishida, M. Yamaguchi, R. Koketsu, K. Hirai, Y. Zhuang, M. Kuramochi, H. Arai, S. Ueki, J. Nishida, S. D. Kamath, K. Matsumoto, J. Sakabe, K. Yamamoto, J. Kihara, Y. Minegishi, J. Chihara, M. Iikura, C. Wong, K. Ohta, T. Tanigai, H. Kato, Y. Tokura, T. Toda, A. Kawakami, H. Takamatsu, A. Lochmanova, C. Ra, R. O'Hehir, O. Mimura, M. Nakano, A. Kumanogoh, Y. Kojima, K. Fukuda, K. Ito, S. Matsuba-Kitamura, K. Mukai, S. Hidano, H. Kayaba, S. S. Sun, A. Lopata, S. Futatsugi-Yumikura, J. Cao, R. Geha, V. Novak, Y. Yin, R. Goitsuka, E. Kuroda, C. W. K. Lam, K. Nakanishi, Y. Taki, H. Karasuyama, A. Komiya, D. Kitamura, C. Lam, M. Takeda, G. Mackay, H. Tashimo, M. Egawa, Y. Nakagawa, L. Chaves, A. Fukushima, O. Skopkova
Publikováno v:
International Immunology. 22:ii131-ii134
Autor:
N. Inagaki, T. Matsubara, H. Kim, Y. Khotimchenko, M. Yamashita, Z. Pourpak, H. Mizuguchi, K. Watanabe, K. Bae, M. Nakaya, A. Majd, D. Lee, J. Jin, L. Taala, R. Geha, H. Kwon, M. Masuoka, S. M. Lind, S. So, T. Ito, A. Luster, A. Scheynius, T. Shahrestani, J. Yoon, C. Johansson, H. Luo, Y. Kitamura, N. Watanabe, K. Hashimoto, M. Mesdaghi, N. S. Koshkarova, M. Vodjgani, K. Terasawa, Y. Kohno, T. Nakayama, M. Iwai, L. Lundeberge, M. Chen, H. Lim, Y. Kim, S. Suzuki, E. Salehi, H. Shiraishi, S. Matsushita, R. Afshar, S. Makino, M. Kitajima, M. Kanno, T. I. Salikova, H. Sutoh, T. Namiki, T. Higashi, B. Chiang, W. Kuroda, M. Irago, N. Sergeeva, R. He, I. Wang, A. A. Denisov, H. Inoue, N. Takeda, O. Kwon, H. Janakiraman, N. Shimojo, K. Izuhara, R. Bogdanovich, M. Oyoshi, Y. Chen, N. Shimojyo, S. Ohta, R. Takagi, Y. Hirasaki, C. Iwamura, K. Sugiura, F. Lee, M. Furue, J. Hadjati, Y. Li, M. C. I. Karlsson, V. V. Klimov, K. Shinoda, Y. Tomita, H. Fukui, K. Su, T. V. Koshovkina, A. Sarrafnejad, Y. Muro
Publikováno v:
International Immunology. 22:iii64-iii67
Autor:
J.P. Maroni, I. Reibel, J.L. Sablayrolles, P. Barsoum Mikhaïl, F. Digne, M. Nejjari, F. Walylo, R. Geha
Publikováno v:
Annales de Cardiologie et d'Angéiologie. 66:359
Introduction L’angioplastie coronaire est un challenge quotidien. Depuis son avenement dans les annees 1980, bon nombre de progres a ete realise notamment grâce aux stents actifs, nous permettant d’etendre les indications d’angioplastie. Il de
Publikováno v:
The Journal of Immunology. 158:2932-2938
Expression of CD40 on cells involved in the inflammatory response has lead to speculation that CD40 ligation could play an important role in the establishment of the inflammatory response. Upon treatment of wild-type CD40 mice with soluble CD40L-CD8
Autor:
C. Vrikshajanani, J. Pastoriza, Wadih Arap, Thomas J. Quinn, G. Alemu, Asha Adem, G. Syrkin, Ziqiang Yuan, Steven K. Libutti, Renata Pasqualini, R. Geha, T. Smith, H. Cho, C. J. Barrett
Publikováno v:
Cancer Gene Therapy
In the current study, we examined whether the combination of tumor vasculature-targeted gene therapy with adeno-associated virus bacteriophage-tumor necrosis factor-α (AAVP-TNF-α) and/or the orally administered LCL161, an antagonist of inhibitors o
Publikováno v:
The Journal of Immunology. 148:1025-1030
We observe that PBMC from most adults (16 of 18 subjects tested) show a small but significant in vitro proliferative response to a 30-amino acid-long peptide (peptide 2, amino acids 34-63) derived from toxic shock syndrome toxin. By contrast, PBMC fr